About ResMed Inc.
ResMed Inc. (RMD) has been publicly traded since 1995, making it a 31-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in San Diego, United States. With a market capitalization of $34 billion, RMD is a large established company.
Key Statistics
- Current Price
- $230.84
- Market Cap
- $33.69B
- 52-Week High
- $293.81
- 52-Week Low
- $199.92
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -3.94% | $240.31 | $230.84 |
| 2025 | +6.26% | $226.15 | $240.31 |
| 2024 | +34.18% | $168.53 | $226.15 |
| 2023 | -16.55% | $201.95 | $168.53 |
| 2022 | -19.47% | $250.77 | $201.95 |
| 2021 | +23.41% | $203.20 | $250.77 |
| 2020 | +38.33% | $146.89 | $203.20 |
| 2019 | +37.85% | $106.56 | $146.89 |
| 2018 | +36.38% | $78.14 | $106.56 |
| 2017 | +39.06% | $56.19 | $78.14 |
| 2016 | +18.01% | $47.62 | $56.19 |
| 2015 | -2.29% | $48.73 | $47.62 |
| 2014 | +21.63% | $40.06 | $48.73 |
| 2013 | +15.24% | $34.77 | $40.06 |
| 2012 | +65.09% | $21.06 | $34.77 |
| 2011 | -26.67% | $28.72 | $21.06 |
| 2010 | +32.54% | $21.67 | $28.72 |
| 2009 | +39.46% | $15.54 | $21.67 |
| 2008 | -28.65% | $21.78 | $15.54 |
| 2007 | +6.72% | $20.40 | $21.78 |
| 2006 | +28.48% | $15.88 | $20.40 |
| 2005 | +49.94% | $10.59 | $15.88 |
| 2004 | +23.01% | $8.61 | $10.59 |
| 2003 | +35.88% | $6.34 | $8.61 |
| 2002 | -43.30% | $11.18 | $6.34 |
| 2001 | +35.22% | $8.27 | $11.18 |
| 2000 | +91.02% | $4.33 | $8.27 |
| 1999 | -7.99% | $4.70 | $4.33 |
| 1998 | +222.67% | $1.46 | $4.70 |
| 1997 | +27.84% | $1.14 | $1.46 |
| 1996 | +69.23% | $0.67 | $1.14 |
Valuation
RMD currently trades at a trailing P/E ratio of 22.8, which is considered moderate relative to the broader market. The forward P/E of 19.0 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 5.3. The price-to-sales ratio is 6.2.
Dividends
ResMed Inc. pays a dividend to shareholders with a current yield of 1.04%. This translates to $2.40 per share annually. The payout ratio of 22% indicates sustainable dividend coverage.
Risk & Volatility
RMD has a beta of 0.89, indicating it is similarly volatile to the overall market. The stock's 52-week range is $199.92 to $293.81, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 15 analyst opinions, RMD has a consensus "buy" rating. The average price target of $296.87 suggests 28.6% upside from current levels.
Frequently Asked Questions
What does ResMed Inc. do? ▼
ResMed Inc. is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in San Diego, United States.
What sector is RMD in? ▼
RMD operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did RMD go public? ▼
ResMed Inc. went public in 1995, making it a 31-year-old public company as of 2026.
How much would $1,000 invested in RMD 5 years ago be worth today? ▼
A $1,000 investment in RMD five years ago would be worth approximately $1,322 today, representing a 32.2% return.
Does RMD pay dividends? ▼
Yes, ResMed Inc. pays a dividend with a current yield of 1.04%, which is $2.4 per share annually.
What is RMD's market cap? ▼
ResMed Inc. has a market capitalization of $34 billion, classifying it as a large-cap company.
What is RMD's P/E ratio? ▼
RMD has a trailing P/E ratio of 22.8 and a forward P/E of 19.0, which measures how much investors are paying per dollar of earnings.
Is RMD a buy, hold, or sell? ▼
Based on 15 opinions, RMD has a consensus "buy" rating. The average price target is $296.87.
Last updated: 3/14/2026